Last updated: February 26, 2019
Sponsor: The Leeds Teaching Hospitals NHS Trust
Overall Status: Active - Recruiting
Phase
N/A
Condition
Scleroderma
Treatment
N/AClinical Study ID
NCT03857152
RD17/91109
Ages 50-70 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Recalled for second stage screening due to microcalcifications on the mammogram
Renal function is within normal limits
No known allergies to contrast
Able to give informed consent
Exclusion
Exclusion Criteria:
Known allergy to contrast
Renal impairment
Unable to provide informed consent
Having radioactive iodine treatment for hyperthyroidism
Study Design
Total Participants: 250
Study Start date:
December 03, 2018
Estimated Completion Date:
February 02, 2021
Connect with a study center
Leeds Teaching Hospitals NHS Trust
Leeds, LS1 3HE,
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.